StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
91
This year
7
Publishing Date
2022 - 10 - 11
1
2022 - 09 - 28
1
2022 - 09 - 24
1
2022 - 09 - 19
1
2022 - 09 - 12
1
2022 - 09 - 11
1
2022 - 08 - 30
1
2022 - 08 - 29
1
2022 - 08 - 22
1
2022 - 08 - 18
1
2022 - 08 - 10
1
2022 - 07 - 22
1
2022 - 07 - 12
1
2022 - 06 - 27
1
2022 - 06 - 05
1
2022 - 04 - 21
1
2022 - 04 - 10
1
2022 - 04 - 06
1
2022 - 04 - 02
1
2022 - 03 - 23
1
2022 - 03 - 16
1
2022 - 03 - 09
1
2022 - 03 - 08
1
2022 - 02 - 14
1
2022 - 02 - 01
1
2022 - 01 - 20
2
2022 - 01 - 13
1
2022 - 01 - 10
1
2021 - 12 - 10
1
2021 - 11 - 12
1
2021 - 10 - 07
1
2021 - 10 - 01
1
2021 - 09 - 16
1
2021 - 08 - 23
1
2021 - 08 - 13
1
2021 - 07 - 12
1
2021 - 07 - 01
1
2021 - 06 - 04
1
2021 - 05 - 28
4
2021 - 05 - 24
1
2021 - 05 - 21
1
2021 - 05 - 20
1
2021 - 05 - 05
1
2021 - 04 - 23
1
2021 - 04 - 22
1
2021 - 04 - 19
1
2021 - 04 - 16
1
2021 - 04 - 14
1
2021 - 04 - 13
1
2021 - 04 - 12
1
2021 - 04 - 07
1
2021 - 03 - 18
1
2021 - 02 - 16
1
2021 - 01 - 28
1
2021 - 01 - 26
1
2021 - 01 - 12
1
2021 - 01 - 11
1
2020 - 12 - 16
1
2020 - 12 - 08
1
2020 - 12 - 04
1
Sector
Finance
2
Health services
3
Health technology
91
Manufacturing
8
N/a
4
Technology services
3
Tags
Acquisition
9
Alliances
7
America
30
Antibody
10
Application
12
Approval
22
Asia
8
Biosimilar
21
Biotech-bay
28
Biotech-beach
13
Cancer
91
Cell
7
Clinical-trials-phase-iii
9
Collaboration
10
Companies
11
Conference
35
Deadline
21
Disease
26
Drug
54
Earnings
9
Eb613
11
Europe
15
Events
15
Expected
10
Fda
23
Financial
25
Financial results
13
Gene therapy
7
Global
83
Growing
15
Growth
102
Health
10
Leukemia
10
Liver
7
Lumakras
15
Lung
7
Lung cancer
16
Market
219
N/a
568
Osteoporosis
11
People
26
Pharma
12
Pharmaceuticals
8
Phase 2
15
Phase 3
7
Positive
14
Potential
9
Psoriasis
12
Reach
8
Report
58
Research
45
Results
53
Risk
9
Set
8
Technology
12
Therapeutics
68
Therapy
42
Treatment
46
Trial
13
Update
8
Entities
Abbott laboratories
2
Abbvie inc.
24
Adaptimmune therapeutics plc
2
Adc therapeutics sa
5
Adobe inc.
1
Affimed n.v.
2
Agenus inc.
1
Agios pharmaceuticals, inc.
10
Alnylam pharmaceuticals, inc.
10
Alphabet inc.
1
Amgen inc.
91
Aptevo therapeutics inc.
2
Aptinyx inc.
1
Astellas pharma inc
8
Astrazeneca plc
28
Aveo pharmaceuticals, inc.
10
Bausch health companies inc.
2
Baxter international inc.
5
Beigene, ltd.
27
Biogen inc.
2
Biontech se
1
Blueprint medicines corporation
10
Bridgebio pharma, inc.
1
Bristol-myers squibb company
23
Bruker corporation
1
Candel therapeutics inc
1
Chemocentryx, inc.
6
Clovis oncology, inc.
10
Crinetics pharmaceuticals, inc.
1
Eli lilly and company
16
Epizyme, inc.
10
Exelixis, inc.
12
F-star therapeutics inc.
2
Genmab a/s
2
Glaxosmithkline plc
24
Guardant health, inc.
1
Icad inc.
2
Illumina, inc.
10
Incyte corporation
10
Jazz pharmaceuticals plc
3
Johnson & johnson
8
Karyopharm therapeutics inc.
10
Laboratory corporation of america holdings
1
Merck & company, inc.
1
Mereo biopharma group plc
2
Merus n.v.
2
Mirati therapeutics, inc.
1
Morgan stanley
2
Novartis ag
28
Pfizer, inc.
10
Puma biotechnology inc
3
Regeneron pharmaceuticals, inc.
10
Rigel pharmaceuticals, inc.
10
Sanofi
32
Takeda pharmaceutical company limited
4
Teva pharmaceutical industries ltd
10
Ucb s.a.
2
Verastem, inc.
10
Viatris inc.
5
Y-mabs therapeutics, inc.
10
Symbols
A
27
ABBV
53
ABT
48
ALPMF
49
ALPMY
49
AMGN
91
ANIX
48
ARAY
26
AVEO
24
AZN
144
AZNCF
74
BCTX
50
BDX
26
BGNE
58
BIOC
31
BMY
107
BPMC
27
CLVS
33
CSTL
28
EXAS
56
EXEL
43
FNCTF
138
GH
53
GILD
59
GLAXF
46
GNPX
26
GSK
54
GTHX
27
HOLX
32
HOTH
29
IBRX
29
ILMN
68
IMGN
25
IMMP
34
INCY
57
JAGX
36
JNJ
138
KPTI
27
LLY
139
LTRN
24
MRK
75
MRTX
32
MYGN
50
NTRA
38
NVCR
30
NVS
106
NVSEF
91
NVTA
25
ONCY
41
PDSB
34
PFE
66
QGEN
31
REGN
42
SGEN
55
SNY
215
SNYNF
165
TAK
34
TMO
51
VCYT
45
VSTM
25
Exchanges
Amex
1
Nasdaq
91
Nyse
54
Crawled Date
2022 - 10 - 19
1
2022 - 10 - 11
1
2022 - 09 - 28
1
2022 - 09 - 24
1
2022 - 09 - 19
1
2022 - 09 - 12
2
2022 - 08 - 30
1
2022 - 08 - 29
1
2022 - 08 - 22
1
2022 - 08 - 18
1
2022 - 08 - 10
1
2022 - 07 - 22
1
2022 - 07 - 12
1
2022 - 06 - 27
1
2022 - 06 - 05
1
2022 - 04 - 21
1
2022 - 04 - 10
1
2022 - 04 - 06
1
2022 - 04 - 02
1
2022 - 03 - 23
1
2022 - 03 - 16
1
2022 - 03 - 09
1
2022 - 03 - 08
1
2022 - 02 - 14
1
2022 - 02 - 01
1
2022 - 01 - 20
2
2022 - 01 - 13
1
2022 - 01 - 10
1
2021 - 12 - 10
1
2021 - 11 - 12
1
2021 - 10 - 07
1
2021 - 10 - 01
1
2021 - 09 - 16
1
2021 - 08 - 23
1
2021 - 08 - 13
1
2021 - 07 - 12
1
2021 - 07 - 02
1
2021 - 06 - 04
1
2021 - 05 - 28
4
2021 - 05 - 24
1
2021 - 05 - 21
1
2021 - 05 - 20
1
2021 - 05 - 05
1
2021 - 04 - 23
1
2021 - 04 - 22
1
2021 - 04 - 19
1
2021 - 04 - 16
1
2021 - 04 - 14
1
2021 - 04 - 13
1
2021 - 04 - 12
1
2021 - 04 - 07
1
2021 - 03 - 18
1
2021 - 02 - 17
1
2021 - 01 - 28
1
2021 - 01 - 26
1
2021 - 01 - 12
1
2021 - 01 - 11
1
2020 - 12 - 16
1
2020 - 12 - 08
1
2020 - 12 - 04
1
Crawled Time
00:00
5
01:00
3
02:00
3
03:00
2
04:00
1
04:20
2
05:00
2
06:00
1
07:00
2
08:00
4
09:00
3
11:00
3
12:00
2
13:00
3
13:50
1
14:00
2
14:30
1
15:00
2
15:20
1
16:00
6
16:20
3
17:00
5
17:37
1
18:00
4
18:04
1
18:26
1
18:31
2
18:33
1
18:40
1
18:42
1
19:00
4
20:00
2
20:08
1
20:59
1
21:00
3
21:11
1
22:00
2
23:00
8
Source
www.biospace.com
14
www.fda.gov
10
www.globenewswire.com
1
www.prnewswire.com
66
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
tags :
Cancer
symbols :
Amgn
save search
Chemotherapy Induced Peripheral Neuropathy Treatment Market Projected Strong Growth to $2.25 Billion by 2028 Amid Advancements in Cancer Treatment
Published:
2024-03-07
(Crawled : 00:00)
- prnewswire.com
ABT
|
$105.9
-3.03%
0.07%
12M
|
Health Technology
|
-7.78%
|
O:
1.41%
H:
0.0%
C:
0.0%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-3.09%
|
O:
1.62%
H:
0.0%
C:
0.0%
QDEL
|
$38.68
-4.02%
-4.19%
750K
|
Health Technology
|
-5.99%
|
O:
1.14%
H:
4.36%
C:
3.16%
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
-3.61%
|
O:
-0.1%
H:
0.18%
C:
-1.25%
cancer
treatment
growth
market
Non-Small Cell Lung Cancer (NSCLC) Market to Reach $29.95 Billion by 2028, Fueled by Advances in Therapy and Diagnostics
Published:
2024-02-22
(Crawled : 01:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
-5.87%
|
O:
0.14%
H:
0.0%
C:
-0.0%
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-3.75%
|
O:
0.26%
H:
1.36%
C:
1.36%
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
6.54%
|
O:
-0.85%
H:
1.12%
C:
0.43%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-8.14%
|
O:
0.92%
H:
0.0%
C:
0.0%
UCBJY
|
$63.31
-4.38%
9.4K
|
Manufacturing
|
24.38%
|
O:
1.46%
H:
0.44%
C:
0.44%
ALPMY
|
$9.34
-1.11%
690K
|
Manufacturing
|
-16.01%
|
O:
-0.27%
H:
0.0%
C:
-1.17%
TAK
|
$13.155
-0.57%
0.0%
1.6M
|
Health Technology
|
-10.24%
|
O:
-0.2%
H:
0.14%
C:
-0.48%
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
-9.5%
|
O:
-0.06%
H:
0.46%
C:
0.29%
GSK
|
$39.6
-0.88%
0.0%
2.8M
|
Health Technology
|
-4.74%
|
O:
-0.69%
H:
1.42%
C:
1.22%
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
0.11%
|
O:
2.37%
H:
1.51%
C:
0.79%
BMY
|
$47.84
-0.87%
-0.02%
12M
|
Health Technology
|
-5.21%
|
O:
-0.65%
H:
1.63%
C:
1.48%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
-7.82%
|
O:
-0.88%
H:
1.46%
C:
1.13%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-2.67%
|
O:
1.67%
H:
0.0%
C:
0.0%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
4.88%
|
O:
-2.81%
H:
2.08%
C:
1.38%
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
-5.95%
|
O:
-0.35%
H:
1.15%
C:
0.96%
lung
reach
cancer
cell
diagnostics
therapy
market
9.18% CAGR growth in Cancer Biologics Market by Product (Monoclonal antibodies, Cell and gene therapy, vaccines, and others), Route Of Administration, and Geography- Global forecast to 2028
Published:
2024-02-19
(Crawled : 16:00)
- prnewswire.com
BIIB
|
$192.13
-1.55%
-1.57%
1.3M
|
Health Technology
|
Email alert
Add to watchlist
VTRS
|
$11.095
-0.22%
-0.23%
6.1M
|
Health Technology
|
Email alert
Add to watchlist
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
Email alert
Add to watchlist
GSK
|
$39.6
-0.88%
0.0%
2.8M
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
Email alert
Add to watchlist
JAZZ
|
$107.15
-1.61%
-1.63%
590K
|
Health Technology
|
Email alert
Add to watchlist
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
cancer
cell
global
growth
market
Blood Cancer Drugs Market Report 2023: Reveals Striking Growth Prospects with a Surge in R&D Activities - Long-term Forecasts to 2028 and 2033
Published:
2024-02-06
(Crawled : 00:00)
- prnewswire.com
ALPMF
|
$9.594
43.47%
2.2K
|
Health Technology
|
-13.72%
|
O:
-1.53%
H:
0.0%
C:
0.0%
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
1.09%
|
O:
-0.37%
H:
0.0%
C:
0.0%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-8.98%
|
O:
0.41%
H:
0.0%
C:
0.0%
UCBJY
|
$63.31
-4.38%
9.4K
|
Manufacturing
|
35.39%
|
O:
1.71%
H:
1.28%
C:
0.94%
ALPMY
|
$9.34
-1.11%
690K
|
Manufacturing
|
-14.23%
|
O:
0.28%
H:
0.18%
C:
0.0%
TAK
|
$13.155
-0.57%
0.0%
1.6M
|
Health Technology
|
-6.57%
|
O:
0.07%
H:
0.42%
C:
0.07%
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
-10.53%
|
O:
0.09%
H:
0.39%
C:
-0.36%
JNJ
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-7.25%
|
O:
1.47%
H:
0.0%
C:
0.0%
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
5.92%
|
O:
0.76%
H:
4.31%
C:
2.11%
BMY
|
$47.84
-0.87%
-0.02%
12M
|
Health Technology
|
-2.03%
|
O:
-0.14%
H:
0.35%
C:
-1.12%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
-4.96%
|
O:
1.48%
H:
0.0%
C:
0.0%
VRTX
|
$393.1
-0.27%
-0.27%
880K
|
Health Technology
|
-5.28%
|
O:
0.15%
H:
2.4%
C:
0.56%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-1.42%
|
O:
1.33%
H:
0.0%
C:
0.0%
JAZZ
|
$107.15
-1.61%
-1.63%
590K
|
Health Technology
|
-12.68%
|
O:
-0.02%
H:
0.0%
C:
-1.4%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
1.83%
|
O:
-0.4%
H:
0.19%
C:
-0.33%
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
-15.65%
|
O:
-0.18%
H:
0.0%
C:
-6.22%
report
cancer
blood
growth
market
Breast Cancer Therapeutics Market 2023, USD 15.64 billion Growth is Expected between 2023 to 2028, Robust pipeline and new drug approvals to Boost Growth - Technavio
Published:
2024-01-30
(Crawled : 18:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
4.69%
|
O:
5.68%
H:
0.77%
C:
0.77%
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
3.09%
|
O:
3.41%
H:
0.0%
C:
-2.45%
VTRS
|
$11.095
-0.22%
-0.23%
6.1M
|
Health Technology
|
-5.84%
|
O:
-0.08%
H:
3.47%
C:
-0.25%
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
-13.86%
|
O:
-2.04%
H:
0.19%
C:
-1.97%
GSK
|
$39.6
-0.88%
0.0%
2.8M
|
Health Technology
|
2.2%
|
O:
4.04%
H:
1.57%
C:
-3.02%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
-1.44%
|
O:
0.5%
H:
0.07%
C:
-0.81%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-8.75%
|
O:
1.75%
H:
0.0%
C:
0.0%
PBYI
|
$5.18
1.57%
1.54%
250K
|
Health Technology
|
7.03%
|
O:
-0.1%
H:
2.31%
C:
-1.26%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
1.58%
|
O:
0.82%
H:
0.12%
C:
-1.64%
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
-15.26%
|
O:
0.44%
H:
0.2%
C:
-0.55%
drug
breast
expected
cancer
pipeline
therapeutics
growth
market
Castration-Resistant Prostate Cancer (CRPC) Treatment Market size to grow by USD 5.98 billion from 2023 to 2028, North America to account for 47% of market growth- Technavio
Published:
2024-01-09
(Crawled : 03:00)
- prnewswire.com
ALPMF
|
$9.594
43.47%
2.2K
|
Health Technology
|
-22.38%
|
O:
0.16%
H:
0.0%
C:
-3.88%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-11.87%
|
O:
-0.24%
H:
0.0%
C:
0.0%
ALPMY
|
$9.34
-1.11%
690K
|
Manufacturing
|
-23.94%
|
O:
-1.22%
H:
0.0%
C:
-0.72%
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
-13.32%
|
O:
-0.46%
H:
0.74%
C:
-0.19%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-10.98%
|
O:
0.74%
H:
0.0%
C:
0.0%
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
-14.25%
|
O:
-0.92%
H:
0.63%
C:
-0.25%
america
cancer
treatment
market
Cancer Immunotherapy Market to grow by USD 38.57 billion from 2022 to 2027, North America to account for 41% of market growth- Technavio
Published:
2024-01-04
(Crawled : 23:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
3.48%
|
O:
2.46%
H:
0.0%
C:
0.0%
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-9.56%
|
O:
0.49%
H:
0.6%
C:
-0.83%
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
-1.27%
|
O:
0.15%
H:
1.88%
C:
-1.17%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-10.82%
|
O:
-0.24%
H:
1.43%
C:
1.43%
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
-12.08%
|
O:
0.32%
H:
0.93%
C:
0.38%
GSK
|
$39.6
-0.88%
0.0%
2.8M
|
Health Technology
|
2.25%
|
O:
-0.36%
H:
0.98%
C:
0.72%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-10.08%
|
O:
-0.14%
H:
0.0%
C:
0.0%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
-0.75%
|
O:
-0.68%
H:
0.87%
C:
0.1%
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
-12.06%
|
O:
-0.32%
H:
0.44%
C:
0.26%
america
cancer
immunotherapy
market
Global Cancer Immunotherapy Market Poised to Exceed US$ 188 Billion by 2030, with CAGR of 10.02%
Published:
2023-12-14
(Crawled : 01:00)
- prnewswire.com
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
-6.91%
|
O:
-1.67%
H:
1.17%
C:
0.85%
JNJ
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-6.05%
|
O:
1.81%
H:
0.0%
C:
0.0%
BMY
|
$47.84
-0.87%
-0.02%
12M
|
Health Technology
|
-6.94%
|
O:
1.16%
H:
0.14%
C:
-1.89%
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
-5.34%
|
O:
-0.11%
H:
0.5%
C:
-1.78%
cancer
global
immunotherapy
market
FDA Grants Priority Review to Amgen's Tarlatamab Application for Advanced Small Cell Lung Cancer
Published:
2023-12-13
(Crawled : 21:00)
- prnewswire.com
BGNE
S
|
$131.885
-1.62%
-1.64%
200K
|
Health Technology
|
-26.88%
|
O:
0.91%
H:
2.03%
C:
1.4%
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
-5.34%
|
O:
-0.11%
H:
0.5%
C:
-1.78%
fda
lung
review
cancer
cell
application
grants
advanced
US Kidney Cancer Therapeutics and Diagnostics Market to 2028, Featuring Profiles of Amgen, Hoffman-La Roche, Bayer, Pfizer, Bristol Myers Squibb and Novartis
Published:
2023-12-12
(Crawled : 01:00)
- prnewswire.com
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
-2.46%
|
O:
1.56%
H:
0.51%
C:
0.51%
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
-4.58%
|
O:
0.45%
H:
0.75%
C:
0.46%
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
-2.04%
|
O:
1.83%
H:
0.04%
C:
-1.13%
kidney
cancer
novartis
diagnostics
therapeutics
market
Fallopian Tube Cancer Therapeutics Market size to grow by USD 832.01 million from 2023-2028| AbbVie Inc., Amgen Inc., Arrien Pharmaceuticals LLC and more among the key companies in the market - Technavio
Published:
2023-12-05
(Crawled : 23:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
14.06%
|
O:
1.64%
H:
0.0%
C:
-1.33%
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
7.6%
|
O:
1.51%
H:
0.13%
C:
-1.68%
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
-4.28%
|
O:
0.52%
H:
0.18%
C:
-0.43%
GSK
|
$39.6
-0.88%
0.0%
2.8M
|
Health Technology
|
9.96%
|
O:
-0.03%
H:
0.28%
C:
-0.41%
BAX
|
$39.52
-0.13%
0.0%
2.8M
|
Health Technology
|
10.53%
|
O:
0.14%
H:
0.78%
C:
0.22%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
12.43%
|
O:
0.26%
H:
0.0%
C:
0.0%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
6.65%
|
O:
0.73%
H:
0.06%
C:
-1.38%
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
-1.58%
|
O:
0.2%
H:
0.2%
C:
-0.76%
GOOGL
|
$155.45
0.68%
0.68%
21M
|
Technology Services
|
19.4%
|
O:
1.97%
H:
0.0%
C:
0.0%
GOOG
|
$156.88
0.56%
0.56%
16M
|
Technology Services
|
19.41%
|
O:
1.97%
H:
0.0%
C:
0.0%
ADBE
|
$474.62
-0.34%
-0.34%
2M
|
Technology Services
|
-20.92%
|
O:
0.97%
H:
0.08%
C:
-2.03%
tube
companies
abbvie
cancer
pharmaceuticals
therapeutics
market
Laryngeal Cancer Therapeutics Market size to grow by USD 575.25 million from 2022-2027| Accord Healthcare Ltd., Amgen Inc., AstraZeneca Plc, Athenex Inc. and more among the major companies in the market- Technavio
Published:
2023-12-01
(Crawled : 23:00)
- prnewswire.com
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
TEVJF
|
$12.37
-24.22%
380
|
Health Technology
|
Email alert
Add to watchlist
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
Email alert
Add to watchlist
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
Email alert
Add to watchlist
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
companies
astrazeneca
cancer
therapeutics
market
Increasing Prevalence of Laryngeal Cancer Fuels Growth in Laryngeal Cancer Therapeutics Market
Published:
2023-10-27
(Crawled : 02:00)
- prnewswire.com
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-12.48%
|
O:
-18.18%
H:
0.0%
C:
0.0%
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
8.01%
|
O:
-1.1%
H:
0.18%
C:
-1.98%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-13.68%
|
O:
-15.73%
H:
0.0%
C:
0.0%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
7.66%
|
O:
-0.42%
H:
0.13%
C:
-1.99%
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
-1.15%
|
O:
-0.28%
H:
0.15%
C:
-2.74%
cancer
therapeutics
growth
market
AMGEN PRESENTS NEW LUMAKRAS® (SOTORASIB) PLUS VECTIBIX® (PANITUMUMAB) DATA IN PATIENTS WITH KRAS G12C-MUTATED METASTATIC COLORECTAL CANCER
Published:
2023-10-22
(Crawled : 16:20)
- prnewswire.com
CCXI
|
$51.99
-0.04%
|
Health Technology
|
Email alert
Add to watchlist
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
Email alert
Add to watchlist
BGNE
S
|
$131.885
-1.62%
-1.64%
200K
|
Health Technology
|
Email alert
Add to watchlist
BEIGF
|
$14.29
-9.87%
2.1K
|
n/a
|
Email alert
Add to watchlist
lumakras
cancer
plus
AMGEN PRESENTS NEW TARLATAMAB DATA IN SMALL CELL LUNG CANCER
Published:
2023-10-20
(Crawled : 12:00)
- prnewswire.com
BGNE
S
|
$131.885
-1.62%
-1.64%
200K
|
Health Technology
|
-15.52%
|
O:
-1.33%
H:
5.87%
C:
5.53%
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
-4.99%
|
O:
0.0%
H:
0.16%
C:
-0.64%
lung
cancer
cell
Minimal Residual Disease Testing Global Markets and Technology Research Report 2023-2028: Charting Cancer Treatment Trajectories - The Role of MRD Explored
Published:
2023-08-25
(Crawled : 14:30)
- prnewswire.com
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
-0.51%
|
O:
-3.27%
H:
3.65%
C:
3.36%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
0.55%
|
O:
0.22%
H:
0.6%
C:
0.31%
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
3.89%
|
O:
0.19%
H:
0.25%
C:
-0.28%
disease
report
cancer
treatment
research
global
technology
Global Peptide Therapeutics Market Report 2023: Increasing Prevalence of Cancer and Metabolic Disorders Drives Growth
Published:
2023-06-08
(Crawled : 02:00)
- prnewswire.com
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
-7.89%
|
O:
0.07%
H:
0.0%
C:
-1.7%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
14.25%
|
O:
1.32%
H:
0.0%
C:
-0.62%
TAK
|
$13.155
-0.57%
0.0%
1.6M
|
Health Technology
|
-17.78%
|
O:
-0.62%
H:
0.88%
C:
0.81%
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
-5.77%
|
O:
1.26%
H:
1.08%
C:
0.91%
GSK
|
$39.6
-0.88%
0.0%
2.8M
|
Health Technology
|
16.27%
|
O:
0.41%
H:
0.68%
C:
0.64%
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
71.13%
|
O:
-0.11%
H:
2.66%
C:
2.24%
BMY
|
$47.84
-0.87%
-0.02%
12M
|
Health Technology
|
-25.94%
|
O:
0.28%
H:
0.42%
C:
-0.05%
BNTX
|
$86.42
0.09%
0.09%
1.2M
|
Health Technology
|
-21.09%
|
O:
0.39%
H:
0.15%
C:
-0.79%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
-6.88%
|
O:
-0.23%
H:
1.83%
C:
1.52%
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
20.49%
|
O:
0.0%
H:
0.28%
C:
-0.23%
metabolic
report
cancer
global
therapeutics
growth
market
Global Blood Cancer Drugs Market Report 2023: Increasing Prevalence of Blood Cancer Cases Drives Growth
Published:
2023-05-16
(Crawled : 22:00)
- prnewswire.com
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
-10.51%
|
O:
-1.32%
H:
0.92%
C:
-1.34%
JNJ
|
$144.77
0.22%
-0.01%
9.3M
|
Health Technology
|
-9.34%
|
O:
0.28%
H:
0.17%
C:
-0.5%
BMY
|
$47.84
-0.87%
-0.02%
12M
|
Health Technology
|
-27.99%
|
O:
0.06%
H:
0.43%
C:
-0.79%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
13.43%
|
O:
-0.19%
H:
0.35%
C:
0.23%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
-9.32%
|
O:
0.07%
H:
0.03%
C:
-0.84%
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
16.99%
|
O:
-0.82%
H:
0.03%
C:
-0.44%
report
cancer
blood
global
growth
market
Targeted Therapy Global Market Report 2023: Increasing Prevalence of Cancer Drives Growth
Published:
2023-05-15
(Crawled : 17:00)
- prnewswire.com
GNMSF
|
$285.11
3.83%
420
|
Health Technology
|
-32.17%
|
O:
0.24%
H:
0.66%
C:
0.66%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
7.89%
|
O:
-1.1%
H:
0.0%
C:
0.0%
TAK
|
$13.155
-0.57%
0.0%
1.6M
|
Health Technology
|
-19.23%
|
O:
0.61%
H:
0.3%
C:
0.24%
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
-10.01%
|
O:
0.2%
H:
0.13%
C:
-0.22%
GSK
|
$39.6
-0.88%
0.0%
2.8M
|
Health Technology
|
9.36%
|
O:
0.27%
H:
0.6%
C:
0.41%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-15.2%
|
O:
0.38%
H:
0.0%
C:
0.0%
GMAB
|
$28.51
-3.13%
-3.23%
360K
|
Health Technology
|
-29.41%
|
O:
0.38%
H:
0.91%
C:
0.69%
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
14.44%
|
O:
0.14%
H:
0.28%
C:
0.11%
report
cancer
global
therapy
growth
market
Breast cancer therapeutics market size grow by USD 13.85 billion between 2021 to 2026; AbbVie Inc. and Amgen Inc., among others, emerge as key vendors - Technavio
Published:
2023-04-13
(Crawled : 09:00)
- prnewswire.com
GLAXF
|
$20.2
-14.18%
510
|
Health Technology
|
8.89%
|
O:
0.54%
H:
0.0%
C:
0.0%
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-18.66%
|
O:
-1.1%
H:
0.0%
C:
0.0%
AZNCF
|
$135.305
-4.19%
1.1K
|
Health Technology
|
-8.11%
|
O:
0.0%
H:
1.63%
C:
1.63%
NVSEF
|
$93.6375
6.88%
82K
|
Health Technology
|
16.68%
|
O:
1.25%
H:
0.51%
C:
0.51%
VTRS
|
$11.095
-0.22%
-0.23%
6.1M
|
Health Technology
|
13.24%
|
O:
0.31%
H:
1.42%
C:
0.71%
NVS
|
$93.08
-0.13%
0.86%
1.2M
|
Health Technology
|
-3.78%
|
O:
1.3%
H:
0.56%
C:
0.51%
GSK
|
$39.6
-0.88%
0.0%
2.8M
|
Health Technology
|
5.94%
|
O:
0.85%
H:
0.76%
C:
0.76%
ABBV
|
$164.25
1.05%
-0.76%
4M
|
Health Technology
|
0.11%
|
O:
-0.84%
H:
1.16%
C:
1.05%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-17.97%
|
O:
0.29%
H:
0.0%
C:
0.0%
PBYI
|
$5.18
1.57%
1.54%
250K
|
Health Technology
|
75.26%
|
O:
-0.34%
H:
10.17%
C:
6.9%
AZN
|
$68.53
0.39%
0.39%
3.7M
|
Health Technology
|
-7.45%
|
O:
0.39%
H:
1.05%
C:
0.97%
AMGN
|
$264.07
-0.59%
-0.59%
2.2M
|
Health Technology
|
6.85%
|
O:
-0.36%
H:
1.33%
C:
1.14%
abbvie
breast
cancer
therapeutics
market
← Previous
1
2
3
4
5
Next →
Gainers vs Losers
57%
43%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
1.9M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
800K
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.